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TENASCIN AND WOUND HEALING IN THE HUMAN CORNEA. 
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Purpose: Tenascin is an extracellular matrix glycoprotein which is expressed 
transiently in wound healing in human skin and animal corneas. In virro and 
ednbryological studies suggest that tenascin mediates cell adhesion/anti-adhesion, 
enhancunen~mlubltion of cell proliiation, and promotion of cell migration. At 
present there are no published data regarding human comeal wound healing, 
therefore we have examined tenascin expression in corneas of histopathology 
specimens obtained because of previous trauma. 
Method: 6um sections were cut from globes with perforating comeal injury 
(20). blunt corncal h-jury (5) and 5 penetrating keratoplasty specimens in which 
there had been previous surgery Cases were selected to encompass a range of 
time intervals between injury and removal (range <24 hours to 90 years). 10 
globes enucleated for choroidal melanoma provided normal corneas. Tenascin 
was demonstrated with a monoclonal antibody specific for human tenascin 
@alto TN2). revealed by an avidin-biotin peroxidase complex (ABC) technique. 
Results: Strong TN2 immunopositivity was observed in regions of active 
inflammation, fibroblastic activity and vascularisation. Corneas from globes 
which had been mucleated within 7 days following injury were tenascin negative, 
while those which had mmained in situ for over 7 days were positive. However, 
no tenasin was detected in mature, avascular scar tissue, Normal corneas were 
tenascin negative. 
Condusien: These results indicate that there is a temporal sequence of tenascin 
expression in human comeal wound healing This, together with the expression 
oftenascin in areas of fibroblastic activity and vascularisation supports the view 
that tenascin is involved in human comeal wound healing processes. 
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P- Certain growth factors, or an applied electric field(EF) induce 
directional migration of cultured corncal cpithelial cells (CEC). Serum in 
culture medium dramaticallv lowers the threshold for electric fmld induced 
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epithelial cells. Both dissociated cells and cell-sheets show enhanced 
responsiveness to EF in the prescuce of serum. We have studied the 
interaction of growth factors with EF in promoting directed cell migration. 
Mel/rook Serum free medium and medll with EGF, bFGF and TGF were 
exchanged into primary cultures of bovine CEC immediitcly prior to field 
application. Serial photographs were taken and analyzed. 
h&j& Cells in serum free medii showed no diional migration. 
EGF (epidermsl growth factor), bFGF (fibrohlast growth facto-basic) and 
TGF (transforming growth factor-hem 1) induced perpendicular reorientation 
and promoted dissociated cell and cell sheet migration toward the cathode 
At a field strength of lSOmV/mm, there was a significant increase in the 
proportion of cells realigning perpendicular to the EF. Additionally, in bFGF 
and TGF cell sheets expanded to cower a greater area, by extending 
membrane preferentially towards the (cathode. The optimal concentrations of 
growth factors producing significant cathodal migration at lSOmV/mm were, 
EGF 25ng/ml:4.8fo.8Umm, bFGF HKtng/ml:4.6fo.8um’h, TGF lpg/ml: 
5.OfLOutwh. This represents a restordtion of migration to ahout one thii of 
the control migration rate in swum (13.3iZ2.6udh). The growth factors also 
restored cathodol migration of epithelii sheets to nearly half of the control 
rate with serum (17iL9umb). 
&z&sions Interactions of single growth factors with an applied EF 
promotes cell migration in vitro. Using combinations of these and other 
growth factors may prove useful in of clinical attempts to promote corneal 
wound hcaUhg. (suppotted by the Wellcome Trust) 
A SIMPLE ORGAN CULTURE MODEL FOR CORNEAL WOUND 
REALING STUDIES: THE EFFECT OF GROWTH FACTORS 
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Purpose. To develop a simple organ culture model with which to study the 
mechanisms of comeal re-epithelialisation and the effect of growth factors. 
Methods. Excisional ttwhhte and enithelial scrape wounds were created on 
was then filled with an agar/coBag~mixture. Organ cuhurc was undertaken at 
37°C in a humidified 5% COr incubator with serum-free Medium 199 maintahted 
at the level of the conjtmctival epithelium. Rates of re-epithelialisation in 
response to addition of exogenous epidermal growth factor (EGF), basic 
fibmblast growth factor (bFGF) and tmnsfotming growth factor type B, (TGFB,) 
were assessed by image analysis. 
Resuh. Comeal cultums could be maintained for upto 3 weeks without 
significant stromal oedema or keratocyte deterioration and with little loss of 
cpithelial architecture. Following wounding the cornea re-epithelialiscd in a 
similar fasbiott to that observed in viva i.e. a lag phase followed by 
migratio~pmliiemtion and the reformation of an intact multilayered epithelitmt. 
EGF accelerated, basic FGF had no effect on, and TGF-8, inhibited the rate of 
comeal re-epitheliiisation. 
Concl~9bms. This simple organ cultum model offers many of the advantages of 
animal models while overcoming many of the disadvantages of cell culture. In 
particular, it a) maintains the corneal architecture, b) allows interaction between 
the different cell types in the cornea i.e. keratocytes and epithclial cells, c) takes 
into account the role of liibal cells and centripetal migration, d) enables the 
specific effect of exogenous factors to be evaluated, and e) permits the use of 
human tissue. 
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